Canada · Delayed Price · Currency is CAD Kits Eyecare Statistics
Total Valuation
Kits Eyecare has a market cap or net worth of CAD 453.50 million. The enterprise value is 437.15 million.
| Market Cap | 453.50M |
| Enterprise Value | 437.15M |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Kits Eyecare has 34.00 million shares outstanding. The number of shares has increased by 0.47% in one year.
| Current Share Class | 34.00M |
| Shares Outstanding | 34.00M |
| Shares Change (YoY) | +0.47% |
| Shares Change (QoQ) | +0.73% |
| Owned by Insiders (%) | 26.00% |
| Owned by Institutions (%) | 14.27% |
| Float | 14.66M |
Valuation Ratios
The trailing PE ratio is 133.21 and the forward PE ratio is 49.72.
| PE Ratio | 133.21 |
| Forward PE | 49.72 |
| PS Ratio | 2.13 |
| PB Ratio | 6.49 |
| P/TBV Ratio | 15.71 |
| P/FCF Ratio | 77.73 |
| P/OCF Ratio | 75.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 39.25, with an EV/FCF ratio of 74.93.
| EV / Earnings | 125.55 |
| EV / Sales | 2.05 |
| EV / EBITDA | 39.25 |
| EV / EBIT | 49.14 |
| EV / FCF | 74.93 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.08.
| Current Ratio | 1.71 |
| Quick Ratio | 0.84 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.51 |
| Debt / FCF | 0.97 |
| Interest Coverage | 15.83 |
Financial Efficiency
Return on equity (ROE) is 5.32% and return on invested capital (ROIC) is 11.10%.
| Return on Equity (ROE) | 5.32% |
| Return on Assets (ROA) | 5.33% |
| Return on Invested Capital (ROIC) | 11.10% |
| Return on Capital Employed (ROCE) | 11.87% |
| Weighted Average Cost of Capital (WACC) | 5.37% |
| Revenue Per Employee | 1.21M |
| Profits Per Employee | 19,784 |
| Employee Count | 176 |
| Asset Turnover | 2.04 |
| Inventory Turnover | 5.23 |
Taxes
In the past 12 months, Kits Eyecare has paid 2.21 million in taxes.
| Income Tax | 2.21M |
| Effective Tax Rate | 38.83% |
Stock Price Statistics
The stock price has increased by +4.18% in the last 52 weeks. The beta is 0.20, so Kits Eyecare's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | +4.18% |
| 50-Day Moving Average | 13.60 |
| 200-Day Moving Average | 15.89 |
| Relative Strength Index (RSI) | 61.92 |
| Average Volume (20 Days) | 157,007 |
Short Selling Information
The latest short interest is 14,456, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 14,456 |
| Short Previous Month | 16,245 |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.18% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kits Eyecare had revenue of CAD 213.33 million and earned 3.48 million in profits. Earnings per share was 0.10.
| Revenue | 213.33M |
| Gross Profit | 78.52M |
| Operating Income | 8.90M |
| Pretax Income | 5.69M |
| Net Income | 3.48M |
| EBITDA | 10.13M |
| EBIT | 8.90M |
| Earnings Per Share (EPS) | 0.10 |
Balance Sheet
The company has 21.98 million in cash and 5.63 million in debt, with a net cash position of 16.35 million or 0.48 per share.
| Cash & Cash Equivalents | 21.98M |
| Total Debt | 5.63M |
| Net Cash | 16.35M |
| Net Cash Per Share | 0.48 |
| Equity (Book Value) | 69.91M |
| Book Value Per Share | 2.06 |
| Working Capital | 23.22M |
Cash Flow
In the last 12 months, operating cash flow was 6.01 million and capital expenditures -172,000, giving a free cash flow of 5.83 million.
| Operating Cash Flow | 6.01M |
| Capital Expenditures | -172,000 |
| Depreciation & Amortization | 1.24M |
| Net Borrowing | -5.21M |
| Free Cash Flow | 5.83M |
| FCF Per Share | 0.17 |
Margins
Gross margin is 36.80%, with operating and profit margins of 4.17% and 1.63%.
| Gross Margin | 36.80% |
| Operating Margin | 4.17% |
| Pretax Margin | 2.67% |
| Profit Margin | 1.63% |
| EBITDA Margin | 4.75% |
| EBIT Margin | 4.17% |
| FCF Margin | 2.73% |
Dividends & Yields
Kits Eyecare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.47% |
| Shareholder Yield | -0.47% |
| Earnings Yield | 0.77% |
| FCF Yield | 1.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Kits Eyecare is 21.96, which is 50.31% higher than the current price. The consensus rating is "Buy".
| Price Target | 21.96 |
| Price Target Difference | 50.31% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 11.96% |
| EPS Growth Forecast (3Y) | 71.77% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Kits Eyecare has an Altman Z-Score of 10.26 and a Piotroski F-Score of 7.
| Altman Z-Score | 10.26 |
| Piotroski F-Score | 7 |